Physician profile
Brian Murphy
NPI 1104877125
$2,528.98
in general payments reported to CMS, 2019-2025
18 companies · $21.41 in 2025
The $21.41 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $1,321 · 2021: $435 · 2022: $232 · 2023: $207 · 2024: $188 · 2025: $21.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $377 · Education: $39.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $376.87 |
| Education | $39.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rigel Pharmaceuticals, INC. | $1,200.00 | 2020 | |
| Beigene USA, INC. | $277.26 | 2021-2023 | Brukinsa |
| E.R. Squibb & Sons, L.L.C. | $270.42 | 2019-2024 | Augtyro |
| Takeda Pharmaceuticals U.S.A., INC. | $107.60 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $103.25 | 2023-2024 | Libtayo |
| Astrazeneca Pharmaceuticals LP | $95.00 | 2021 | |
| Seagen INC. | $79.99 | 2021 | |
| Incyte Corporation | $76.97 | 2022 | |
| Janssen Biotech, INC. | $60.99 | 2021 | |
| Sobi, INC | $60.36 | 2024 | |
| Merck Sharp & Dohme LLC | $54.56 | 2019-2023 | Keytruda |
| Pfizer INC. | $34.86 | 2021 | |
| Novartis Pharmaceuticals Corporation | $23.56 | 2019 | |
| Taiho Oncology, INC. | $23.50 | 2022 | |
| Medtronic, INC. | $21.41 | 2025 | Venaseal |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $13.70 | 2019 | |
| Glaxosmithkline, LLC. | $13.63 | 2020 | |
| Gilead Sciences, INC. | $11.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.